Search

Your search keyword '"Bevacizumab -- Ethical aspects"' showing total 2 results
Start Over Descriptor "Bevacizumab -- Ethical aspects"
2 results on '"Bevacizumab -- Ethical aspects"'

1. Bevacizumab for eye diseases - Legal, regulatory, and ethical overview

Author

Jose, Vinu, Radhakrishna, Swetha, Pipalava, Parag, and Singh, Inderjeet

Subjects
United States. Food and Drug Administration -- Ethical aspects, Diseases, Ethical aspects, Cancer treatment, Ophthalmic agents -- Ethical aspects, Ramucirumab, Bevacizumab -- Ethical aspects, Vascular endothelial growth factor, Eye diseases, Pegaptanib, Endothelium, Angiogenesis inhibitors, Endothelial growth factors, Aflibercept, Ranibizumab
Published
2019

2. Data on Retinal Diseases and Conditions Reported by Researchers at University of Missouri - Kansas City (Off-label use of bevacizumab in the treatment of retinal disease: ethical implications)

Subjects
University of Missouri-Kansas City -- Ethical aspects, Care and treatment, Ethical aspects, Bevacizumab -- Ethical aspects, Retinal diseases -- Care and treatment, Vascular endothelial growth factor, Medical research, Immunotherapy, Colorectal cancer -- Care and treatment, Endothelium, Eye diseases, Angiogenesis inhibitors, Antineoplastic agents, Endothelial growth factors, Editors
Abstract

2019 DEC 18 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Researchers detail new data in Eye Diseases and Conditions - Retinal Diseases and Conditions. According [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results